Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Eplontersenwainuahcp.com · Low evidenceWAINUA (eplontersen) is a treatment for adults with hereditary transthyretin-mediated amyloidosis polyneuropathy (hATTR PN) designed to stop polyneuropathy progression and improve quality of life. The product is developed by AstraZeneca and targets the underlying cause of the disease to help healthcare professionals manage patient care.
Parse Score